The Effect of Single and Double Dose Platelet Apheresis on Platelet Count A Thrombopoietin Levels and Percentage of Immature Platelet Fraction of Donor Post Donation
DOI:
https://doi.org/10.24036/eksakta/vol27-iss02/663Keywords:
Platelet, Thrombopoietin, Platelet apheresis, Platelet countAbstract
Thrombapheresis is commonly used to obtain platelet concentrates; however, different collection doses may affect donor hematological responses. This study aimed to compare the effects of single-dose and double-dose thrombapheresis on platelet count, thrombopoietin (TPO) levels, and immature platelet fraction (IPF). A prospective comparative study with repeated measures was conducted in eight healthy donors (n = 8; 4 per group) at the Indonesian Red Cross Blood Donation Unit, Tangerang. Blood samples were collected before, immediately after, and on day 2 and day 4 post-donation. Platelet count and IPF were measured using an automated hematology analyzer, while TPO levels were assessed by ELISA. Data were analyzed using two-way ANOVA and Pearson correlation (p < 0.05). Platelet counts decreased immediately after thrombapheresis (23% in single-dose; 24% in double-dose) and gradually recovered. Significant effects of time and dose were observed (p < 0.05), but no difference between groups at day 4 (p > 0.05). TPO increased in both groups (50% vs 27%), and IPF changes were not significant (p > 0.05). A positive but non-significant correlation between TPO and IPF was found. Both procedures cause transient platelet reduction with gradual recovery. Findings should be interpreted cautiously due to the small sample size.
Downloads
References
[1] Agarwal, A., Khan, A. I., & Anwer, F. (2024). Platelet transfusion. In StatPearls [Internet]. StatPearls Publishing.
[2] Allard, S. (2009). Blood transfusion. Medicine, 37(3), 172-176.
[3] Carson, J. L., Stanworth, S. J., Guyatt, G., Valentine, S., Dennis, J., Bakhtary, S., ... & Pagano, M. B. (2023). Red blood cell transfusion: 2023 AABB international guidelines. Jama, 330(19), 1892-1902.
[4] Statistik, B. P. (2025). Statistik Indonesia 2025: Statistical yearbook of Indonesia 2025 (Vol. 53). Badan Pusat Statistik.
[5] Aji Muhawarman. (2025). Kasus Kanker Diprediksi Meningkat 70 Persen pada 2050, Kemenkes Perkuat Deteksi Dini
[6] Aji Muhawarman. (2025). Nyamuk lebih mematikan daripada hewan buas. Kementerian Kesehatan Republik Indonesia
[7] Lee, E. J., & Lee, A. I. (2016). Thrombocytopenia. Primary Care: Clinics in Office Practice, 43(4), 543-557.
[8] Ramaiah, L., Erkens, T., Sirivelu, M., & Vitsky, A. (2025). Hematopoietic system. In Haschek and Rousseaux's handbook of Toxicologic pathology (pp. 337-436). Academic Press.
[9] Kaushansky, K. (2024). Thrombopoietin, the primary regulator of platelet production: from mythos to logos, a thirty-year journey. Biomolecules, 14(4), 489.
[10] Gauer, R. L., & Braun, M. M. (2012). Thrombocytopenia. American family physician, 85(6), 612-622.
[11] Jeon, K., Kim, M., Lee, J., Lee, J. S., Kim, H. S., Kang, H. J., & Lee, Y. K. (2020). Immature platelet fraction: a useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery. Medicine, 99(7), e19096.
[12] Asghar, M. B., Akhtar, F., Mahmood, A., Rafique, N., Rana, N. A., & Khalid, U. B. (2023). Diagnostic accuracy of immature platelet fraction (IPF) to differentiate between thrombocytopenia due to peripheral destruction versus bone marrow failure. Age (years), 27(19.1), 30-24.
[13] Ali, I., Graham, C., & Dempsey-Hibbert, N. C. (2019). Immature platelet fraction as a useful marker in the etiological determination of thrombocytopenia. Experimental Hematology, 78, 56-61.
[14] Kaufman, R. M., Djulbegovic, B., Gernsheimer, T., Kleinman, S., Tinmouth, A. T., Capocelli, K. E., ... & Tobian, A. A. (2015). Platelet transfusion: a clinical practice guideline from the AABB. Annals of internal medicine, 162(3), 205-213.
[15] Metcalf, R. A., Nahirniak, S., Guyatt, G., Bathla, A., White, S. K., Al-Riyami, A. Z., ... & Stanworth, S. J. (2025). Platelet transfusion: 2025 AABB and ICTMG international clinical practice guidelines. JAMA, 334(7).
[16] Das SS, Sen S, Zaman RU, Biswas RN. (2021). Plateletpheresis in the Era of Automation: Optimizing Donor Safety and Product Quality Using Modern Apheresis Instruments. Indian Journal of Hematology and Blood Transfusion ;37:134–9. https://doi.org/10.1007/s12288-020-01337-1.
[17] Hans, R., Sharma, R. R., & Marwaha, N. (2019). Effect of plateletpheresis on postdonation serum thrombopoietin levels and its correlation with platelet counts in healthy voluntary donors. Asian Journal of Transfusion Science, 13(1), 10-16.
[18] Indonesia, M. K. R. (2015). Standar Pelayanan Transfusi Darah. Pelayanan Transfusi Darah.
[19] Chopra, S., Kaur, P., Bedi, R. K., & Kaur, G. (2023). Effect of double dose plateletpheresis on target yield and donor platelet recovery. Hematology, Transfusion and Cell Therapy, 45(1), 16-24.
[20] Makroo, R. N., Fadadu, D., Agrawal, S., & Chowdhry, M. (2018). Double dose plateletpheresis: a savior to shrinking donor pool and platelet inventory management. Indian Journal of Hematology and Blood Transfusion, 34(4), 691-696.
[21] Thokala, R. P., Radhakrishnan, K., Anandan, A., & Panicker, V. K. (2016). Recovery of platelet count among apheresis platelet donors. Journal of clinical and diagnostic research: JCDR, 10(12), EC01.
[22] Rajput, S., Makroo, R. N., Chowdhry, M., & Thakur, U. K. (2021). Changes in hematological parameters post plateletpheresis: Single center study from North India. Transfusion and Apheresis Science, 60(6), 103283.
[23] Patel, K. B., Inaniya, K., & Padharia, D. P. (2023). Recovery period for attaining baseline haematological parameters after plateletpheresis donation-a cohort study. J Clin Diagn Res, 17(4).
[24] Jiang, H., Jin, Y., Shang, Y., Yuan, G., Liu, D., Li, J., ... & Zhou, F. (2021). Therapeutic plateletpheresis in patients with thrombocytosis: gender, hemoglobin before apheresis significantly affect collection efficiency. Frontiers in Medicine, 8, 762419.
[25] Elsayed, A., Elsayed, B., Elmarasi, M., Elsabagh, A. A., Elsayed, E., Elmakaty, I., & Yassin, M. (2024). Thrombopoietin receptor agonists in post-hematopoietic cell transplantation complicated by prolonged thrombocytopenia: a comprehensive review. ImmunoTargets and Therapy, 461-486.
[26] Hans, R., Sharma, R. R., & Marwaha, N. (2019). Effect of plateletpheresis on postdonation serum thrombopoietin levels and its correlation with platelet counts in healthy voluntary donors. Asian Journal of Transfusion Science, 13(1), 10-16.
[27] Rosyidah, R. A., Anjani, N., Hartini, W. M., & Mardiyaningsih, A. (2023). Perbedaan Jumlah Trombosit Pasca Transfusi Thrombocyte Concentrate Dan Thrombocyte Apheresis Pada Pasien Trombositopenia. Jurnal Kesehatan, 11(1), 169-182.
[28] Kariyawasan, C. C., Botenne, C. S., Balasuriya, B. L. T., Ruhunuhewa, U. S., Dissanayake, D. M. C., & Ranatunga, S. A. C. D. (2024). Diagnostic Utility of Immature Platelet Fraction (IPF) in Differentiating Thrombocytopenia Due to Increased Thrombopoietic Activity. Achievements and Challenges of Medicine and Medical Science Vol. 9, 60-73.
[29] Ding, S., Wang, M., Fang, S., Xu, H., Fan, H., Tian, Y., ... & Sun, X. (2025). Corrigendum: D-dencichine regulates thrombopoiesis by promoting megakaryocyte adhesion, migration and proplatelet formation. Frontiers in Pharmacology, 15, 1504076.
[30] Bajaj, H., Rajpal, T., Sharma, M., Singh, P., Hemal, A., & Kumar, V. (2024). Role of immature platelet fraction in etiological diagnosis of thrombocytopenia. Journal of Laboratory Physicians, 16(4), 496-500.
[31] Zhu, M., Sharma, P., Mete, M., Olcal, A., Ibrahim, I., Chen, W., & Bat, T. (2025). Absolute Immature Platelet Count: An Accessible Biomarker to Distinguish Aplastic Anemia and Immune Thrombocytopenia. International Journal of Laboratory Hematology, 47(2), 357-361.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Aulia Ramadhan Supit, Della Hashfi Anzhari, Saptuti Chunaeni, Rahajuningsih Dharma Setiabudy

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted non-commercial use, distribution and reproduction in any medium
























